Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB ALKEM LABORATORIES DR. REDDYS LAB/
ALKEM LABORATORIES
 
P/E (TTM) x 19.7 37.5 52.5% View Chart
P/BV x 4.4 6.5 67.9% View Chart
Dividend Yield % 0.6 1.0 64.2%  

Financials

 DR. REDDYS LAB   ALKEM LABORATORIES
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
ALKEM LABORATORIES
Mar-23
DR. REDDYS LAB/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs4,6563,625 128.4%   
Low Rs3,7882,835 133.6%   
Sales per share (Unadj.) Rs1,481.4970.1 152.7%  
Earnings per share (Unadj.) Rs270.784.2 321.4%  
Cash flow per share (Unadj.) Rs345.7110.2 313.8%  
Dividends per share (Unadj.) Rs40.0050.00 80.0%  
Avg Dividend yield %0.91.5 61.2%  
Book value per share (Unadj.) Rs1,389.6756.4 183.7%  
Shares outstanding (eoy) m166.53119.57 139.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.83.3 85.6%   
Avg P/E ratio x15.638.4 40.7%  
P/CF ratio (eoy) x12.229.3 41.6%  
Price / Book Value ratio x3.04.3 71.2%  
Dividend payout %14.859.4 24.9%   
Avg Mkt Cap Rs m703,039386,207 182.0%   
No. of employees `000NANA-   
Total wages/salary Rs m46,46621,314 218.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,697115,993 212.7%  
Other income Rs m10,5552,161 488.5%   
Total revenues Rs m257,252118,153 217.7%   
Gross profit Rs m63,86015,065 423.9%  
Depreciation Rs m12,5023,104 402.7%   
Interest Rs m1,4281,074 133.0%   
Profit before tax Rs m60,48513,048 463.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,4122,980 517.3%   
Profit after tax Rs m45,07310,068 447.7%  
Gross profit margin %25.913.0 199.3%  
Effective tax rate %25.522.8 111.6%   
Net profit margin %18.38.7 210.5%  
BALANCE SHEET DATA
Current assets Rs m203,16186,064 236.1%   
Current liabilities Rs m85,72137,071 231.2%   
Net working cap to sales %47.642.2 112.7%  
Current ratio x2.42.3 102.1%  
Inventory Days Days7933 243.1%  
Debtors Days Days10767 159.8%  
Net fixed assets Rs m112,63837,245 302.4%   
Share capital Rs m833239 348.4%   
"Free" reserves Rs m230,57190,208 255.6%   
Net worth Rs m231,40490,447 255.8%   
Long term debt Rs m1,2780-   
Total assets Rs m315,799124,541 253.6%  
Interest coverage x43.413.2 329.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.9 83.9%   
Return on assets %14.78.9 164.6%  
Return on equity %19.511.1 175.0%  
Return on capital %26.615.6 170.4%  
Exports to sales %52.214.6 358.0%   
Imports to sales %16.80-   
Exports (fob) Rs m128,80316,916 761.4%   
Imports (cif) Rs m41,484NA-   
Fx inflow Rs m128,80316,916 761.4%   
Fx outflow Rs m41,4844,190 990.2%   
Net fx Rs m87,31912,727 686.1%   
CASH FLOW
From Operations Rs m58,87516,825 349.9%  
From Investments Rs m-41,3731,128 -3,666.5%  
From Financial Activity Rs m-26,861-17,608 152.5%  
Net Cashflow Rs m-9,073416 -2,180.0%  

Share Holding

Indian Promoters % 26.7 56.7 47.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 47.3 24.4 193.7%  
FIIs % 28.6 8.5 337.1%  
ADR/GDR % 15.3 0.0 -  
Free float % 58.0 43.3 134.1%  
Shareholders   257,794 65,184 395.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dr. Reddys vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs ALKEM LABORATORIES Share Price Performance

Period Dr. Reddys ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day 1.78% -1.18% 1.18%
1-Month -4.23% -0.99% -0.75%
1-Year 35.93% 52.26% 61.82%
3-Year CAGR 10.85% 21.70% 18.16%
5-Year CAGR 17.77% 22.99% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.